Advertisement
Home 2018

Archives

Overall survival is increased for African-American men with metastatic castration resistant prostate cancer versus Caucasian men treated with docetaxel/prednisone (DP) or a DP-containing regimen

ASCO: Overall Survival Up for African-American Men With mCRPC

0
Improved survival versus Caucasian men treated with docetaxel/prednisone, DP-containing regimen
Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation

ASCO: Undertreatment Seen for Women With Head & Neck Cancer

0
Female patients are less likely to receive intensive chemo, radiation; increased risk for death from HNC
Three assays may detect early lung cancer in blood samples using genome sequencing

ASCO: New Assays May Detect Early Lung Cancer in Blood

0
Targeted sequencing, whole-genome sequencing, whole-genome bisulfite sequencing show potential
For patients with minor psychiatric disorders

DDW: Psych Disorders Make GERD Hard to Dx by Symptoms Alone

0
Symptoms are unreliable for establishing presence of reflux in patients with minor psychiatric disorders
The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer

ASCO: Ovarian Suppression + Tamoxifen Ups Breast CA Survival

0
Increased disease-free, overall survival for premenopausal women with breast cancer
In the field of fecal microbiota transplantation

DDW: Altruism, Economic Reward Motivate Fecal Donation

0
Logistics of collecting and transporting feces was recurrent theme impeding stool donation
A noninvasive method for diagnosing irritable bowel syndrome

DDW: Bowel Sounds May Identify Irritable Bowel Syndrome

0
Recording of bowel sounds allowed for IBS diagnosis with high sensitivity and specificity
For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer

ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC

0
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
Costs of treatment for metastatic colorectal cancer are significantly higher in Western Washington State than in British Columbia

ASCO: mCRC Costs Up in Western Washington vs. British Columbia

0
No significant difference between regions in median OS for those receiving, not receiving systemic tx
For patients with metastatic renal cell carcinoma classified as having intermediate or poor prognostic risk

ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer

0
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival